Leiden, The Netherlands, May 9, 2007 - Dutch biotechnology company Crucell N.V. (Euronext, Nasdaq: CRXL; Swiss Exchange: CRX) today announced its financial results for the first quarter ended March 31, 2007, based on International Financial Reporting Standards (IFRS). These financial results are unaudited.
